Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats-Reference-Cited by-同舟云学术

Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats

Published:2011-08-30 Issue:11 Volume:55 Page:1655-1665
ISSN:1613-4125
Container-title:Molecular Nutrition & Food Research
language:en
Short-container-title:Mol. Nutr. Food Res.

Author:

Soetikno Vivian,Watanabe Kenichi,Sari Flori R.,Harima Meilei,Thandavarayan Rajarajan A.,Veeraveedu Punniyakoti T.,Arozal Wawaimuli,Sukumaran Vijayakumar,Lakshmanan Arun Prasath,Arumugam Somasundaram,Suzuki Kenji

Publisher

Wiley

Subject

Food Science,Biotechnology

Reference51 articles.

1. Diabetic nephropathy;Zelmanovitz;Diabetol. Metab. Syndr.,2009

2. Diabetic nephropathy: Mechanisms of renal disease progression;Kanwar;Exp. Biol. Med.,2008

3. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator;Sharma;Diabetes,1995

4. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis;Riser;J. Am. Soc. Nephrol.,2000

5. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes;Remuzzi;J. Clin. Invest.,2006

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potential of Curcumin, a Bioactive Compound of Turmeric, in Prevention of Streptozotocin-Induced Diabetes through the Modulation of Oxidative Stress and Inflammation;Molecules;2023-12-25

2. Development of Dual-Responsive Fluorescent Probe for Drug Screening of Diabetes Cardiomyopathy;Chemical & Biomedical Imaging;2023-12-11

3. Pathomechanisms of Diabetic Kidney Disease;Journal of Clinical Medicine;2023-11-27

4. Fennel Essential Oil as a Complementary Therapy in the Management of Diabetes;Pharmaceutics;2023-11-23

5. Potential implications of protein kinase Cα in pathophysiological conditions and therapeutic interventions;Life Sciences;2023-10